Influence of the containment on the epidemiology of maxillo-facial emergencies during the COVID-19 pandemic. Why no more cellulites of odontogenic origin?

Affiliations

¹ Department of oral and maxillo-facial surgery, Angers University Hospital, 4, rue Larrey, 49933 Angers cedex, France. Electronic address: daniel.kun-darbois@univ-angers.fr.
² Department of oral and maxillo-facial surgery, Angers University Hospital, 4, rue Larrey, 49933 Angers cedex, France.
³ Department of oral and maxillo-facial surgery, Nantes University Hospital, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.

Comment

J D Kün-Darbois et al. J Stomatol Oral Maxillofac Surg. 2020 Sep.

. 2020 Sep;121(4):467-468.

doi: 10.1016/j.jormas.2020.05.005. Epub 2020 May 13.

¹ Department of oral and maxillo-facial surgery, Angers University Hospital, 4, rue Larrey, 49933 Angers cedex, France. Electronic address: daniel.kun-darbois@univ-angers.fr.
² Department of oral and maxillo-facial surgery, Angers University Hospital, 4, rue Larrey, 49933 Angers cedex, France.
³ Department of oral and maxillo-facial surgery, Nantes University Hospital, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.

No abstract available

Keywords: Cellulitis; Coronavirus; Non-steroidal anti-inflammatory drugs.

Comment on

The impact of the COVID-19 epidemic on the utilization of emergency dental services.
Guo H, Zhou Y, Liu X, Tan J. Guo H, et al. J Dent Sci. 2020 Dec;15(4):564-567. doi: 10.1016/j.jds.2020.02.002. Epub 2020 Mar 16. J Dent Sci. 2020. PMID: 32296495 Free PMC article.

1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. - PMC - PubMed
1. Guo H., Zhou Y., Liu X., Tan J. The impact of the COVID-19 epidemic on the utilization of emergency dental services. J Dent Sci. 2020 doi: 10.1016/j.jds.2020.02.002. - DOI - PMC - PubMed
1. Giollo A., Adami G., Gatti D., Idolazzi L., Rossini M. Coronavirus disease 19 (COVID-19) and non-steroidal anti-inflammatory drugs (NSAID) Ann Rheum Dis. 2020;0:1. doi: 10.1136/annrheumdis-2020-217598. [Article Epub ahead of print] - DOI - PubMed
1. Little P. Non-steroidal anti-inflammatory drugs and covid-19. BMJ. 2020;368:m1185. doi: 10.1136/bmj.m1185. - DOI - PubMed
1. Weill A., Drouin J., Desplas D., Dray-Spira R., Zureik M. Agence nationale de sécurité du médicament et des produits de santé, pp. 1-134; 2020. Usage des médicaments de ville en France durant l’épidémie de COVID-19 – point de situation à la fin mars 2020. [ https://www.ansm.sante.fr/S-informer/Actualite/Usage-des-medicaments-en-...]